Rachel Freeman
- Epidemiology
- Applied Microbiology and Biotechnology top 2%
- Infectious Diseases
- Molecular Medicine top 10%
- Clinical Biochemistry top 10%
- Co-authors
- Alison HolmesAndré CharlettLuke MooreLeticia García-ÁlvarezHugo DonaldsonBerit Müller‐PebodyJulie V. RobothamKoen B. Pouwels
- Topics
- Antibiotic Use and Resistance (11 papers)Antibiotic Resistance in Bacteria (7 papers)Bacterial Identification and Susceptibility Testing (5 papers)
- Partner nations
- United KingdomUgandaUnited States
In The Last Decade
Rachel Freeman
22 papers receiving 327 citations
Peers
Comparison fields: 5 of 81
- Epidemiology 121
- Applied Microbiology and Biotechnology 97
- Infectious Diseases 71
- Molecular Medicine 69
- Clinical Biochemistry 44
Countries citing papers authored by Rachel Freeman
This map shows the geographic impact of Rachel Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Freeman more than expected).
Fields of papers citing papers by Rachel Freeman
This network shows the impact of papers produced by Rachel Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Freeman. The network helps show where Rachel Freeman may publish in the future.
Co-authorship network of co-authors of Rachel Freeman
This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Freeman. A scholar is included among the top collaborators of Rachel Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Freeman. Rachel Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 2 | |
| 5 | 5 | |
| 6 | 9 | |
| 7 | Hepatitis E in Namibia: A Historical Review | 1 |
| 8 | 8 | |
| 9 | 8 | |
| 10 | 2 | |
| 11 | 32 | |
| 12 | 17 | |
| 13 | 1 | |
| 14 | 52 | |
| 15 | 5 | |
| 16 | 21 | |
| 17 | 14 | |
| 18 | 34 | |
| 19 | 81 | |
| 20 | 12 |
About Rachel Freeman
Rachel Freeman is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 23 papers that have together received 332 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (11 papers), Antibiotic Resistance in Bacteria (7 papers) and Bacterial Identification and Susceptibility Testing (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (97 citations), Molecular Medicine (69 citations) and Clinical Biochemistry (44 citations). Rachel Freeman has collaborated with scholars based in United Kingdom, Uganda and United States. Frequent co-authors include Alison Holmes, André Charlett, Luke Moore, Leticia García-Álvarez, Hugo Donaldson, Berit Müller‐Pebody, Julie V. Robotham, Koen B. Pouwels, Katherine L. Henderson and Timo Smieszek. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, BMC Medicine and Journal of Pain and Symptom Management.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.